Propanc Biopharma (PPCB) News Today → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free PPCB Stock Alerts $0.0011 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePropanc Biopharma Receives Certificate of Grant for "Composition of Proenzymes for Cancer Treatment" Patent from European Patent Officefinance.yahoo.com - April 16 at 10:19 AMPropanc Biopharma's CEO Shares Views on Revolutionizing Cancer Treatment: An Inside Look at Drug Development & Strategic Financingstockhouse.com - April 10 at 1:59 AMPropanc Biopharma’s CEO Shares Views on Revolutionizing Cancer Treatment: An Inside Look at Drug Development & Strategic Financingfinance.yahoo.com - April 8 at 9:07 AMPropanc Biopharma to Host Corporate Update Call Highlighting Recent Progress and Positive Results from Compassionate Use Studyfinance.yahoo.com - February 22 at 12:12 PMPropanc Biopharma Receives Certificate of Grant for PRP Foundation Patent from Canadian Intellectual Property Officefinance.yahoo.com - January 16 at 2:04 PMPropanc Biopharma Engages Boutique Advisory Firm to Identify Strategic Investment Opportunitiesfinance.yahoo.com - December 18 at 10:54 AMPropanc Biopharma’s Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRPfinance.yahoo.com - December 13 at 12:08 PMJames Nathanielsz, CEO of Propanc Biopharma, Inc., is Featured in an Interview With SmallCapsDailyfinance.yahoo.com - December 12 at 7:43 AMPropanc Biopharma, Inc.: Propanc Biopharma Confirms PRP Enhances Chemosensitivity and Alters Tumor Microenvironment of Pancreatic Tumor Cellsfinanznachrichten.de - November 7 at 2:07 PMPropanc Biopharma Confirms PRP Enhances Chemosensitivity and Alters Tumor Microenvironment of Pancreatic Tumor Cellsfinance.yahoo.com - November 7 at 2:07 PMPropanc Biopharma Targets Site of First-In-Human Study for PRP at the Peter Mac Cancer Center, Melbourne, Australiafinance.yahoo.com - August 15 at 5:46 PMPropanc Biopharma’s Clinical Candidate PRP Targeting Pancreatic Cancer Market Forecast to Reach $6.93 Billion by 2030finance.yahoo.com - July 26 at 9:25 AMPropanc Biopharma Peer Reviewed Scientific Article Reaches 3,000 Readsfinance.yahoo.com - July 13 at 8:47 AMPropanc Biopharma Produces Synthetic Recombinant Proenzymes for Cancer Therapy Targeting Advanced Solid Tumorsfinance.yahoo.com - July 5 at 1:39 PMPPCB - Propanc Biopharma, Inc.sg.finance.yahoo.com - June 30 at 8:59 AMPROPANC BIOPHARMA INC (PPCB) stock forecast and price targetfinance.yahoo.com - June 28 at 7:06 PMPropanc Biopharma’s Intellectual Property Portfolio Makes Important Advancements in Europefinance.yahoo.com - May 25 at 1:29 PMPropanc Biopharma’s Intellectual Property Portfolio Achieves Significant Milestones in North Americafinance.yahoo.com - May 23 at 8:50 AMPropanc Biopharma Announces Reverse Stock Splitfinance.yahoo.com - May 23 at 1:06 AMPropanc Biopharma Announces That PRP Suppresses TGF-β Pathway & Tumor Microenvironment in Pancreatic Cancerfinance.yahoo.com - March 28 at 9:29 AMPropanc Biopharma Confirms PRP Exerts Significant Effects Against Chemoresistant Pancreatic Tumor Cellsfinance.yahoo.com - March 16 at 1:22 PMXeris Biopharma Holdings Stock (NASDAQ:XERS), Analyst Ratings, Price Targets, Predictionsbenzinga.com - March 14 at 5:02 AMPPCB Propanc Biopharma, Inc.seekingalpha.com - February 23 at 9:25 AMPropanc Biopharma’s Joint Researcher Presents at the 43rd Meeting of the European Organization of Research & Treatment of Cancer (EORTC)finance.yahoo.com - January 11 at 1:37 PMPropanc Biopharma, Inc.: Propanc Biopharma's Joint Researcher Receives Award at Doctoral Conference at the University of Jaénfinanznachrichten.de - December 17 at 10:10 AMPropanc Biopharma’s Joint Researcher Receives Award at Doctoral Conference at the University of Jaénfinance.yahoo.com - December 15 at 12:28 PMPropanc Biopharma Concludes PRP Could Become an Effective Chemosensitizer Agent Against Pancreatic Cancerfinance.yahoo.com - November 30 at 1:01 PMPropanc Biopharma’s CSO Predicts PRP Could Enhance Therapeutic Effects of Immune Checkpoint Therapy for Pancreatic Cancerfinance.yahoo.com - November 15 at 10:25 AMPropanc Biopharma’s CEO to Present at Sidoti & Company Micro-Cap Virtual Investor Conferencefinance.yahoo.com - October 26 at 11:12 AMPropanc Biopharma’s CEO to Attend 43rd Meeting of the European Organization of Research & Treatment of Cancer (EORTC), Dec 15 - 17finance.yahoo.com - October 12 at 2:10 PMPropanc Biopharma Targets Pancreatic & Ovarian Cancers for PRP Clinical Studies with Combined Markets to Reach Over $14.3 Billion by 2027finance.yahoo.com - September 29 at 10:45 AMPropanc Biopharma Reports Significant Effects of PRP Against the Tumor Microenvironmentfinance.yahoo.com - September 8 at 10:24 AMPropanc Biopharma Synthesizes Recombinant Trypsinogen & Chymotrypsinogen Via POP1 Joint Research & Drug Discovery Programfinance.yahoo.com - August 23 at 5:29 PMPropanc Biopharma, Inc.: Propanc Biopharma Receives Notice of Allowance for Proenzyme Compositions to Treat Cancer from the European Patent Officefinanznachrichten.de - August 17 at 3:41 PMPropanc Biopharma Receives Notice of Allowance for Proenzyme Compositions to Treat Cancer from the European Patent Officefinance.yahoo.com - August 16 at 9:36 AMPropanc Biopharma, Inc.: Propanc Biopharma Establishes Joint Research Collaboration Agreement with the Universities of Jaén and Granadafinanznachrichten.de - August 3 at 11:31 AMPropanc Biopharma Establishes Joint Research Collaboration Agreement with the Universities of Jaén and Granadafinance.yahoo.com - August 3 at 11:31 AMPropanc Biopharma’s CSO Reflects on Unique Anti-Cancer Effects of PRP Discovered Over Past Decadefinance.yahoo.com - July 28 at 9:55 AMPropanc Biopharma Successfully Produces Synthetic Recombinant Trypsinogen Via POP1 Joint Research & Drug Discovery Programfinance.yahoo.com - July 19 at 1:44 PMPropanc Biopharma's CEO Believes Lead Asset Could Unlock Value as PRP Advances to Phase I, First-In-Human Study in Advanced Cancer Patientsstockhouse.com - July 13 at 11:14 PMPropanc Biopharma Inc Newsthestreet.com - July 13 at 11:14 PMPropanc Biopharma’s CEO Comments on the 39 Granted Patents and 26 Patent Applications Under Examination in Key Global Jurisdictions | Morningstarmorningstar.com - July 6 at 8:59 PMPropanc Biopharma's CEO Comments on the 39 Granted Patents and 26 Patent Applications Under Examination in Key Global Jurisdictionsstockhouse.com - July 6 at 8:59 PMPropanc Biopharma’s CEO Comments on the 39 Granted Patents and 26 Patent Applications Under Examination in Key Global Jurisdictionsfinance.yahoo.com - July 5 at 6:56 PMPropanc Biopharma Announces No Immediate Plans for Reverse Stock Splitfinance.yahoo.com - June 24 at 4:12 PMPropanc Biopharma’s CSO Hails Dostarlimab’s Impressive Results Whilst Acknowledging More Work to Be Done in the Fight Against Cancerfinance.yahoo.com - June 22 at 1:28 PMPropanc Biopharma's PRP to Target 80 - 90% of Cancer Casesstockhouse.com - June 16 at 1:09 PMPropanc Biopharma’s PRP to Target 80 – 90% of Cancer Casesfinance.yahoo.com - June 14 at 1:19 PMPropanc Biopharma Believes PRP Reduced Toxicity Will Impact Cancer Patient Lives Significantlyfinance.yahoo.com - June 1 at 9:17 AMPropanc Biopharma Presents 100 Years of Clinical Evidence for "Novel" Enzyme Therapeutic Approach to Treat Cancerfinance.yahoo.com - May 26 at 11:24 AM Get Propanc Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for PPCB and its competitors with MarketBeat's FREE daily newsletter. Email Address The only accurate crypto trading system I know … (Ad)Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money. Here's what our expert says you should buy before April 14. PPCB Media Mentions By Week PPCB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PPCB News Sentiment▼0.000.44▲Average Medical News Sentiment PPCB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PPCB Articles This Week▼00▲PPCB Articles Average Week Get Propanc Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for PPCB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Wellness Center USA News Statera Biopharma News Predictive Technology Group News Acura Pharmaceuticals News NovAccess Global News Athersys News Boomer News Advanced BioMedical Technologies News Humanigen News Bruush Oral Care News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PPCB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Propanc Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
